The Only Monthly Membership With a Positive ROI!
España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
The Only Monthly Membership With a Positive ROI!
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Abbott Laboratories
ABT
NYSE
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$105.24
-0.72
-0.68%
At Close: -
$100.00
-5.24
-4.98%
After Hours: Jul 26, 7:59 PM EDT
15 minutes delayed
Get Report
Comment
Abbott Laboratories (ABT) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Abbott Laboratories (NYSE:ABT) Stock
Abbott Laboratories Stock (NYSE: ABT)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, July 26, 2024
Abbott Laboratories's Options Frenzy: What You Need to Know
Benzinga Insights
Peering Into Abbott Laboratories's Recent Short Interest
Benzinga Insights
Thursday, July 25, 2024
Behind the Scenes of Abbott Laboratories's Latest Options Trends
Benzinga Insights
Friday, July 19, 2024
Abbott Labs Makes Marketing Push For New Glucose Monitors, Targets Health-Conscious Consumers
Vandana Singh
Dow Plunges Over 500 Points Following Unexpected Surge In US Jobless Claims
Avi Kapoor
Thursday, July 18, 2024
Why Are Abbott Laboratories Shares Trading Lower?
Vaishali Prayag
Nasdaq Down Over 100 Points; Abbott Laboratories Earnings Beat Views
Avi Kapoor
VIX Stages Double-Digit Spike As Risk Off Takes Over; Chipmakers Fail To Rebound, Weight Loss Giants Eli Lilly, Novo Tumble: What's Driving Markets Thursday?
Piero Cingari
Abbott Laboratories shares are trading lower....
Benzinga Newsdesk
Abbott Laboratories Q2 Earnings: Revenue And Profit Beat Estimates, Nudges Up Annual Profit Guidance On Strong Medical Devices Growth
Vandana Singh
Abbott Narrowed Its Full-year 2024 Organic Sa...
Benzinga Newsdesk
Abbott Revises Its Full-year 2024 EPS Guidanc...
Benzinga Newsdesk
Wall Street Gearing Up For Tech-Led Rebound Ahead Of Netflix Earnings: Economist Expects Soft Landing But Says Brace For Bigger Fed Rate Cuts If This Happens
Shanthi Rexaline
Abbott Laboratories Q2 2024 Adj EPS $1.14 Bea...
Benzinga Newsdesk
Nasdaq Sees Worst Session Since 2022 As Chip Stocks Tumble After Trump's Taiwan Remarks and Biden's Potential Restrictions
Avi Kapoor
D.R. Horton, Netflix And 3 Stocks To Watch Heading Into Thursday
Avi Kapoor
Abbott Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Avi Kapoor
Monday, July 15, 2024
Netflix, Goldman Sachs, J&J, ASML Lead Q2 Reports This Week As Analysts See Earnings Growth Accelerating To Fastest In Over 2 Years
Shanthi Rexaline
Thursday, July 11, 2024
Wall Street Bulls Look Optimistic About Abbott: Should You Buy?
Zacks
Wednesday, July 10, 2024
Looking Into Abbott Laboratories's Recent Short Interest
Benzinga Insights
Monday, July 08, 2024
Similac Baby Formula Maker Abbott And Reckitt Face Hundreds Of Baby Formula Lawsuits
Vandana Singh
Friday, July 05, 2024
DexCom, Abbott to Launch First FDA Cleared OTC CGMs
Zacks
Tuesday, July 02, 2024
7 Analysts Have This To Say About Abbott Laboratories
Benzinga Insights
Evercore ISI Group Maintains Outperform on Ab...
Benzinga Newsdesk
Friday, June 28, 2024
FDA Says Abbott Medical Issues Correction For...
Benzinga Newsdesk
Thursday, June 27, 2024
Market Whales and Their Recent Bets on ABT Options
Benzinga Insights
Monday, June 24, 2024
Abbott's EPD Expansion Continues Despite FX Headwind
Zacks
Thursday, June 13, 2024
Abbott Gets FDA Nod for Two Glucose Monitoring Systems
Zacks
Monday, June 10, 2024
Abbott Laboratories's Options: A Look at What the Big Money is Thinking
Benzinga Insights
Abbott Receives FDA Clearance For Its Lingo A...
Benzinga Newsdesk
Friday, June 07, 2024
Class Action Against Abbott's Glucerna Products Proceeds in Federal Court
Vandana Singh
Thursday, June 06, 2024
Abbott Is Considered a Good Investment by Brokers: Is That True?
Zacks
Tuesday, June 04, 2024
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
RBC Capital Reiterates Outperform on Abbott L...
Benzinga Newsdesk
Monday, June 03, 2024
Berkshire Hathaway, Chipotle, More NYSE Stocks Hit With Trading Halts Triggered By Technical Issues (UPDATED)
Piero Cingari
Abbott Shares Resume Trade
Benzinga Newsdesk
Abbott Shares Halted On Circuit Breaker To Th...
Benzinga Newsdesk
Cadrenal Therapeutics Presents New Trial Data...
Benzinga Newsdesk
Thursday, May 30, 2024
Goldman Sachs Initiates Coverage On Abbott La...
Benzinga Newsdesk
Thursday, May 23, 2024
8 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
Wednesday, May 22, 2024
Critical Insights From Abbott Laboratories Analyst Ratings: What You Need To Know
Benzinga Insights
Citigroup Maintains Buy on Abbott Laboratorie...
Benzinga Newsdesk
Tuesday, May 21, 2024
Jim Cramer Calls This Healthcare Stock A 'Worthy Spec,' Recommends Avoiding Canada Goose
Avi Kapoor
Wednesday, May 15, 2024
FDA Says Abbott Recalls Heartmate 3 Left Vent...
Benzinga Newsdesk
Massive Insider Trade At Abbott Laboratories
Benzinga Insights
Tuesday, May 14, 2024
Looking At Abbott Laboratories's Recent Unusual Options Activity
Benzinga Insights
Friday, May 10, 2024
What the Options Market Tells Us About Abbott Laboratories
Benzinga Insights
Thursday, May 09, 2024
Amazon, Abbott Laboratories And 2 Other Stocks Insiders Are Selling
Avi Kapoor
Friday, May 03, 2024
How Is The Market Feeling About Abbott Laboratories?
Benzinga Insights
Wednesday, May 01, 2024
What the Options Market Tells Us About Abbott Laboratories
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch